Valiant Laboratories Limited (NSE:VALIANTLAB)
India
· Delayed Price · Currency is INR 55.77
+2.40 (4.50%)
Mar 9, 2026, 3:29 PM IST
Valiant Laboratories Company Description
Valiant Laboratories Limited operates as an active pharmaceutical ingredient/bulk drug manufacturing company in India and internationally.
The company manufactures paracetamol in various grades, such as Indian/British/European/the United States pharmacopoeias for the treatment of headaches, muscle aches, arthritis, back aches, toothaches, cold, and fever.
It also offers specialty chemicals. The company was formerly known as Bharat Chemicals and changed its name to Valiant Laboratories Limited in August 2021.
The company was founded in 1980 and is based in Mumbai, India. Valiant Laboratories Limited is a subsidiary of Dhanvallabh Ventures LLP.
Valiant Laboratories Limited
| Country | India |
| Founded | 1980 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 79 |
| CEO | Santosh Vora |
Contact Details
Address: 104, Udyog Kshetra Mumbai, 400080 India | |
| Phone | 91 22 4971 2001 |
| Website | valiantlabs.in |
Stock Details
| Ticker Symbol | VALIANTLAB |
| Exchange | National Stock Exchange of India |
| Fiscal Year | April - March |
| Reporting Currency | INR |
| ISIN Number | INE0JWS01017 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Santosh Shantilal Vora | MD and Executive Director |
| Paresh Shashikant Shah | Whole-Time Director and Chief Financial Officer |
| Kiran Mudaliar | Assistant Manager of Accounts |
| Akshay Dnyaneshwar Gangurde C.S. | Company Secretary and Compliance Officer |
| Nilesh Vinayak Patil | Analytical Head |
| Meghana Shivpal Wasnik | Head of Research & Development |
| Jyotibhushan Singh | Executive Director of VASPL |
| Rachi Santosh Vora | Executive Officer |